Recent developments and new directions in the use of natural products for the treatment of inflammatory bowel disease
- 13 June 2024
- journal article
- review article
- Published by Elsevier in Phytomedicine
- Vol. 132, 155812
Abstract
No abstract availableKeywords
Funding Information
- Fujian University of Traditional Chinese Medicine
- National Natural Science Foundation of China
This publication has 275 references indexed in Scilit:
- Crude Tieguanyin oolong tea polysaccharides regulate intestinal immune and gut microflora in dextran sulfate sodium‐induced mice colitisJournal of the Science of Food and Agriculture, 2024
- CP‐25 exerts therapeutic effects in mice with dextran sodium sulfate‐induced colitis by inhibiting GRK2 translocation to downregulate the TLR4‐NF‐κB‐NLRP3 inflammasome signaling pathway in macrophagesIUBMB Life, 2021
- Chlorogenic Acid Suppresses miR‐155 and Ameliorates Ulcerative Colitis through the NF‐κB/NLRP3 Inflammasome PathwayMolecular Nutrition & Food Research, 2020
- Manipulation of epithelial integrity and mucosal immunity by host and microbiota‐derived metabolitesEuropean Journal of Immunology, 2020
- Resveratrol modulates the gut microbiota to prevent murine colitis development through induction of Tregs and suppression of Th17 cellsJournal of Leukocyte Biology, 2019
- The efficacy of curcuminoids in improvement of ulcerative colitis symptoms and patients’ self‐reported well‐being: A randomized double‐blind controlled trialJournal of Cellular Biochemistry, 2018
- Short‐Chain Fatty Acid Transporters: Role in Colonic Homeostasis2017
- Small‐Molecule PROTACS: New Approaches to Protein DegradationAngewandte Chemie International Edition, 2016
- Target Identification Using Drug Affinity Responsive Target Stability (DARTS)Current Protocols in Chemical Biology, 2011
- Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel diseaseInflammatory Bowel Diseases, 2008